Human umbilical cord mesenchymal stem cell therapy (Shanghai East Hospital)

N/A

Report date: 2023/01/19 20:00:22

Base Information

Drug NameHuman umbilical cord mesenchymal stem cell therapy (Shanghai East Hospital)
Drug Alias Name人脐带间充质干细胞疗法-上海东方医院
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Ischemic StrokePost-Acute COVID-19 Syndrome +[15] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai Oriental Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Oriental Hospital
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Ischemic StrokeMyocardial Ischemia +[13] 
Inactive IndicationsPost-Acute COVID-19 SyndromePneumonia

Other Information

ATC CodeN/A
Related LinksN/A